1. Home
  2. HCTI vs PCSA Comparison

HCTI vs PCSA Comparison

Compare HCTI & PCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$2.32

Market Cap

13.5M

Sector

Technology

ML Signal

HOLD

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$0.15

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCTI
PCSA
Founded
2020
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
14.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HCTI
PCSA
Price
$2.32
$0.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
346.9K
1.0M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,942,000.00
N/A
Revenue This Year
$47.01
N/A
Revenue Next Year
$44.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$0.15
52 Week High
$435.75
$1.33

Technical Indicators

Market Signals
Indicator
HCTI
PCSA
Relative Strength Index (RSI) 49.14 27.55
Support Level $2.17 $0.26
Resistance Level $2.54 $0.30
Average True Range (ATR) 0.23 0.03
MACD 0.04 -0.01
Stochastic Oscillator 58.82 19.81

Price Performance

Historical Comparison
HCTI
PCSA

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Share on Social Networks: